Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-11

FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves a supplemental application for glyburide (Teva Pharmaceuticals USA, Inc.).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyburide (glyburide)

Snippet

SUPPL AP for GLYBURIDE (GLYBURIDE)